ProfileGDS4459 / ENSG00000131389
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 55% 51% 57% 41% 57% 56% 55% 42% 64% 54% 63% 55% 52% 53% 58% 56% 56% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.655
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.4451
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.6657
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.241
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.6657
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.656
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.6555
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.0542
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.0364
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.654
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.8163
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.655
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.4952
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.5253
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.7158
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.656
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.656